This month’s healthcare and pharmaceutical headlines reflect the growing influence of politics, corporate strategy, and innovation on public health. Limited FDA approval of some COVID vaccines, major acquisitions to expand treatment portfolios, and advances in AI-assisted fertility care show how decisions around access, investment, and technology are shaping the industry. These developments signal a shift […]
